A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis
RAD18 is an important protein in trans-lesion synthesis, an error-prone damage-tolerant mode of DNA replication. Here the authors show that MAGE-A4 stabilizes RAD18 and allows cancer cells to maintain on-going DNA synthesis in the face of genotoxic injury.
Guardado en:
Autores principales: | Yanzhe Gao, Elizabeth Mutter-Rottmayer, Alicia M. Greenwalt, Dennis Goldfarb, Feng Yan, Yang Yang, Raquel C. Martinez-Chacin, Kenneth H. Pearce, Satoshi Tateishi, Michael B. Major, Cyrus Vaziri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e5d0907f6a14928a23a27cda5802f8e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
por: Carman K. M. Ip, et al.
Publicado: (2018) -
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases
por: Seung Wook Yang, et al.
Publicado: (2020) -
A Case Report and Literature Review of a Novel Mutation in the MAGED2 Gene of a Patient With Severe Transient Polyhydramnios
por: Xiaoxia Wu, et al.
Publicado: (2021) -
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
por: Saeed M, et al.
Publicado: (2016) -
The pathologic effect of a novel neomorphic Fgf9(Y162C) allele is restricted to decreased vision and retarded lens growth.
por: Oliver Puk, et al.
Publicado: (2011)